Journal of Veterinary Internal Medicine

ACVIM Launches Fellowship Program to Advance Veterinary Internal Medicine Expertise

Retrieved on:

Thursday, September 7, 2023

General Health, Consumer, Health, Pets, Veterinary, Veterinary medicine, Private practice, Journal of Veterinary Internal Medicine, Fellow, Gastroenterology, Fellows, Growth, American College, DVM

The American College of Veterinary Internal Medicine (ACVIM) proudly announces the launch of a new Fellowship Program, a transformative initiative designed to advance veterinary expertise and foster collaborative excellence in the field of veterinary internal medicine.

Key Points:

The American College of Veterinary Internal Medicine (ACVIM) proudly announces the launch of a new Fellowship Program, a transformative initiative designed to advance veterinary expertise and foster collaborative excellence in the field of veterinary internal medicine.
The ACVIM Fellowship Program fosters the professional development of an ACVIM Diplomate looking to achieve a level of expertise and mastery in a focused field or discipline.
Making a Significant Contribution to Advancing Veterinary Internal Medicine: The ACVIM Fellowship Program is not just about individual growth; it’s about contributing to the global advancement of veterinary medicine.
"The ACVIM Fellowship Program represents a bold step towards redefining the boundaries of veterinary internal medicine,” said Chair of the Fellowship Committee, Keith Richter, DVM, MSEL, DACVIM (SAIM).

AKC Canine Health Foundation Celebrates 1,000th Scientific Publication

Retrieved on:

Thursday, July 20, 2023

RALEIGH, N.C., July 20, 2023 /PRNewswire/ -- The AKC Canine Health Foundation (CHF), a non-profit organization dedicated to advancing the health and well-being of all dogs, proudly announces the publication of its 1,000th scientific study. This significant milestone demonstrates CHF's unwavering commitment to improving the lives of dogs.

Key Points:

Non-Profit Organization Drives Groundbreaking Canine Health Research, Advancing the Health of Dogs
RALEIGH, N.C., July 20, 2023 /PRNewswire/ -- The AKC Canine Health Foundation (CHF), a non-profit organization dedicated to advancing the health and well-being of all dogs, proudly announces the publication of its 1,000th scientific study.
Dr. Stephanie Montgomery, CHF Chief Executive Officer, emphasizes the profound impact of the Foundation's funding, stating, "The AKC Canine Health Foundation has left an indelible mark on the health and well-being of dogs worldwide.
With an ongoing portfolio of 158 active canine health research studies, CHF supports research that advances the health of dogs.
To be awarded funding, all projects undergo evaluation of scientific merit and the potential to advance canine health by a panel of experts.

The American College of Veterinary Internal Medicine Announces 2023 Recognition Awards

Retrieved on:

Tuesday, July 11, 2023

The American College of Veterinary Internal Medicine (ACVIM) is pleased to announce the recipients of the 2023 ACVIM Recognition Awards.

Key Points:

The American College of Veterinary Internal Medicine (ACVIM) is pleased to announce the recipients of the 2023 ACVIM Recognition Awards.
These accomplished veterinary professionals have demonstrated excellence, dedicated service and expertise, making a significant impact on the wellbeing of animals and advancing the veterinary profession.
The awards were presented during the 2023 ACVIM Forum in Philadelphia, Pennsylvania, before an international audience of ACVIM Diplomates and veterinary professionals.
The award winners are:
Dr. Peter Constable, Dean of the College of Veterinary Medicine at the University of Illinois Urbana-Champaign, is the 2023 recipient of the Robert W. Kirk Award for Professional Excellence for his outstanding career and lifetime of contributions to the ACVIM and veterinary internal medicine.

ANTECH DIAGNOSTICS PRESENTS LARGEST MOLECULAR STUDY ON GI PARASITES IN PETS AT ACVIM, SHARING NEW INSIGHTS ON PREVALENCE IN NORTH AMERICA

Retrieved on:

Friday, June 16, 2023

FOUNTAIN VALLEY, Calif., June 16, 2023 /PRNewswire/ -- Antech Diagnostics presented its largest molecular parasite study1 to date at the American College of Veterinary Internal Medicine's (ACVIM) Forum 2023. The first research abstract of two presented by Antech this year, studied a large subset of fecal samples - over 300,000 - from cats and dogs amassed in the first 10 months following KeyScreen® GI Parasite PCR's 2022 launch.

Key Points:

FOUNTAIN VALLEY, Calif., June 16, 2023 /PRNewswire/ -- Antech Diagnostics presented its largest molecular parasite study1 to date at the American College of Veterinary Internal Medicine's (ACVIM) Forum 2023.
Another KeyScreen study into anthelmintic-resistant canine hookworms in North America had found that the problem is much more widespread across the US.
2 This new data shows that in North America, over 11% of detected canine hookworms were identified with the drug resistance marker 167Y.
KeyScreen is a significant advancement in veterinary diagnostics, providing a powerful tool to detect parasites in a way we have never been able to before.

Veterinary Dentistry Specialists in Mt. Laurel, NJ, Adds a Veterinary Cardiologist to Team of Board-Certified Specialists in Dentistry and Anesthesia

Retrieved on:

Monday, April 10, 2023

Laurel, NJ, office of Veterinary Dentistry Specialists (VDS), a veterinary dentistry and oral surgery practice, has added board-certified veterinary cardiologist Megan King, VMD, DACVIM (Cardiology), to its roster of dental and anesthesia specialists.

Key Points:

Laurel, NJ, office of Veterinary Dentistry Specialists (VDS), a veterinary dentistry and oral surgery practice, has added board-certified veterinary cardiologist Megan King, VMD, DACVIM (Cardiology), to its roster of dental and anesthesia specialists.
Adding comprehensive outpatient veterinary cardiology services makes VDS the first and only veterinary dentistry and oral surgery practice in the nation with anesthesiology and cardiology specialists available to care for each patient.
Cardiology services are also available for pet patients who do not need dentistry services.
She then earned Diplomate status by becoming board certified in veterinary cardiology by the American College of Veterinary Internal Medicine.

Next-Generation Sequencing-Based 'Liquid Biopsy' at Wellness Visits Can Increase Early Detection, PetDx Study Shows

Retrieved on:

Wednesday, February 15, 2023

DNA, Dog, DVM, Journal, Journal of Veterinary Internal Medicine, Physical examination, Veterinary medicine, Cancer, Oncology, Patient, Family, Liquid biopsy, History, SAN, Doctor of Philosophy, Vaccine, Medical imaging

SAN DIEGO, Feb. 15, 2023 /PRNewswire/ -- PetDx® – The Liquid Biopsy Company for Pets™ has published a study of over 350 dogs showing that cancer was detected by the current standard of care at wellness visits, before the onset of clinical signs, in just 4% of dogs. The study, published in the Journal of Veterinary Internal Medicine, suggests that the use of a next-generation sequencing-based "liquid biopsy" screening test has the potential to increase early cancer detection at wellness visits and expand the number of cancer types detectable at these visits. In the study, OncoK9 detected cancer in about half the dogs with preclinical disease.

Key Points:

The study, published in the Journal of Veterinary Internal Medicine, suggests that the use of a next-generation sequencing-based "liquid biopsy" screening test has the potential to increase early cancer detection at wellness visits and expand the number of cancer types detectable at these visits.
In the study, OncoK9 detected cancer in about half the dogs with preclinical disease.
Major veterinary organizations likewise recognize the importance of early cancer detection, but no formal screening guidelines exist.
"Early cancer detection" can be conceptualized as detection of cancer at an early disease stage (i.e., "early-stage detection") or detection of cancer before the onset of clinical signs (i.e., "preclinical detection").

Popular Veterinary Career Site and Continuing Education Provider Launch New Content Partnership

Retrieved on:

Thursday, July 28, 2022

WAUKESHA, Wis., July 28, 2022 /PRNewswire/ -- Vetcetera, an online community for professional development and education for veterinary professionals and students, and Vet Candy, a veterinary news source and continuing education provider, today announced a new partnership that will expand access to continuing education for practicing veterinarians. This partnership provides informative and high quality content that both entertains and educates.

Key Points:

WAUKESHA, Wis., July 28, 2022 /PRNewswire/ -- Vetcetera, an online community for professional development and education for veterinary professionals and students, and Vet Candy, a veterinary news source and continuing education provider, today announced a new partnership that will expand access to continuing education for practicing veterinarians.
Due to limited access to in-person continuing education during COVID-19, online veterinary continuing education options have become increasingly popular.
To help meet the growing demand for veterinary care, the two organizations will collaborate to create and deliver continuing education courses that qualify for approval by the Registry of Approved Continuing Education (RACE).
"By bringing high-quality continuing education content to this popular online community, veterinary pros will receive the engaging content they need to support their full career trajectory from student to practitioner."

US FDA APPROVES QBIOTICS INVESTIGATIONAL NEW DRUG APPLICATION TO INITIATE TIGILANOL TIGLATE SOFT TISSUE SARCOMA PHASE II TRIAL

Retrieved on:

Sunday, July 24, 2022

Evaluate the degree of tumour ablation in tumours and or tumour segments treated with one or more injections of tigilanol tiglate.

Key Points:

Evaluate the degree of tumour ablation in tumours and or tumour segments treated with one or more injections of tigilanol tiglate.
QBiotics' lead oncology product, tigilanol tiglate, is a small molecule targeting a range of solid tumours across multiple species.
Tigilanol tiglate has a multimodal action that involves injected tumour responses as well as systemic responses in non-injected tumours.
Randomized controlled clinical study evaluating the efficacy and safety of intratumoral treatment of canine mast cell tumors with tigilanol tiglate.

US FDA APPROVES QBIOTICS INVESTIGATIONAL NEW DRUG APPLICATION TO INITIATE TIGILANOL TIGLATE SOFT TISSUE SARCOMA PHASE II TRIAL

Retrieved on:

Sunday, July 24, 2022

Evaluate the degree of tumour ablation in tumours and or tumour segments treated with one or more injections of tigilanol tiglate.

Key Points:

Evaluate the degree of tumour ablation in tumours and or tumour segments treated with one or more injections of tigilanol tiglate.
QBiotics' lead oncology product, tigilanol tiglate, is a small molecule targeting a range of solid tumours across multiple species.
Tigilanol tiglate has a multimodal action that involves injected tumour responses as well as systemic responses in non-injected tumours.
Randomized controlled clinical study evaluating the efficacy and safety of intratumoral treatment of canine mast cell tumors with tigilanol tiglate.

LexaGene Announces Webinar by UC Davis Professor on Use of MiQLab® System for Diagnosis of Urinary Tract Infections

Retrieved on:

Tuesday, July 5, 2022

This webinar will provide background information on the difficulties of accurately diagnosing urinary tract infections with conventional technologies.

Key Points:

This webinar will provide background information on the difficulties of accurately diagnosing urinary tract infections with conventional technologies.
Dr. Sykes is a Professor of Small Animal Internal Medicine (Infectious Diseases) and the Executive Director of Innovation and Entrepreneurship in the School of Veterinary Medicine (SVM) at UC Davis.
The MiQLab system delivers excellent sensitivity, specificity, and breadth of detection and can return results in approximately two hours.
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.